被 發 現 含 有 未 標 示 西 藥 的 產 品
|
| |
| Australia: Safety advisory: ITCHA SSS capsules (English only) |
| |
The Therapeutic Goods Administration (TGA) is advising consumers that ITCHA SSS capsules, marketed for weight management, have been found to contain oxedrine, an undisclosed prescription-only (Schedule 4) medicine.
TGA Laboratory testing found that a product labelled ITCHA SSS contained the herb Citrus Aurantium (also known as bitter orange). Oxedrine is found in Citrus Aurantium. The capsules tested contained 60.5mg of oxedrine per capsule.
ITCHA SSS capsules have not been assessed by the TGA for quality, safety or efficacy. The product may pose a serious risk to health. Taking oxedrine without medical supervision can increase the risk of serious side effects, including heart-related problems.
Oxedrine at dosage of greater than 30mg daily is prescription-only medicine and should only be used under medical supervision. Oxedrine can have potential adverse events that include fainting, elevated heart rate, high blood pressure, stroke and heart attack. Monitor for symptoms such as palpitations, dizziness or chest discomfort.
Consumers are advised to stop using ITCHA SSS capsules and take any remaining product to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their healthcare practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/safety/safety-monitoring-and-information/../itcha-sss-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Friday, Jul 3, 2026
Issued at HKT 14:30
|
| |
